Condition
Palliative Treatment
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (2)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting1
Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06511518Not ApplicableRecruiting
Cognitive Behavioral Therapy for Cancer-related Fatigue in Patients With Cancer Receiving Palliative Systemic Treatment
NCT06374160Not ApplicableNot Yet Recruiting
Exercise in Patients With Advanced Non-small Cell Lung Cancer
NCT00408252Phase 2Terminated
Efficacy of SU 011248 in Head And Neck Carcinoma
NCT02166320Phase 2Completed
Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent.
NCT02083211Phase 3Completed
Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma
Showing all 5 trials